RU2705375C2 - Фармацевтические композиции, содержащие антибактериальные агенты - Google Patents

Фармацевтические композиции, содержащие антибактериальные агенты Download PDF

Info

Publication number
RU2705375C2
RU2705375C2 RU2017110457A RU2017110457A RU2705375C2 RU 2705375 C2 RU2705375 C2 RU 2705375C2 RU 2017110457 A RU2017110457 A RU 2017110457A RU 2017110457 A RU2017110457 A RU 2017110457A RU 2705375 C2 RU2705375 C2 RU 2705375C2
Authority
RU
Russia
Prior art keywords
pharmaceutically acceptable
acceptable salt
compound
ertapenem
formula
Prior art date
Application number
RU2017110457A
Other languages
English (en)
Russian (ru)
Other versions
RU2017110457A (ru
RU2017110457A3 (es
Inventor
Махеш Витхалбхай ПАТЕЛ
Сачин БХАГВАТ
Джайкумар Сатваджи САТАВ
Хемант Нарендра КХАНДЕ
Прашант Ратнакар ДЖОШИ
Снехал Рамешвар ПАЛВЕ
Original Assignee
Вокхардт Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Вокхардт Лимитед filed Critical Вокхардт Лимитед
Publication of RU2017110457A publication Critical patent/RU2017110457A/ru
Publication of RU2017110457A3 publication Critical patent/RU2017110457A3/ru
Application granted granted Critical
Publication of RU2705375C2 publication Critical patent/RU2705375C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
RU2017110457A 2014-01-21 2015-01-20 Фармацевтические композиции, содержащие антибактериальные агенты RU2705375C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN193/MUM/2014 2014-01-21
IN193MU2014 IN2014MU00193A (es) 2014-01-21 2015-01-20
PCT/IB2015/050421 WO2015110950A1 (en) 2014-01-21 2015-01-20 Pharmaceutical compositions comprising antibacterial agents

Publications (3)

Publication Number Publication Date
RU2017110457A RU2017110457A (ru) 2018-10-03
RU2017110457A3 RU2017110457A3 (es) 2018-10-03
RU2705375C2 true RU2705375C2 (ru) 2019-11-07

Family

ID=52629621

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017110457A RU2705375C2 (ru) 2014-01-21 2015-01-20 Фармацевтические композиции, содержащие антибактериальные агенты

Country Status (10)

Country Link
US (2) US10322116B2 (es)
EP (1) EP3217979B8 (es)
AU (2) AU2015208830A1 (es)
CA (1) CA2954553C (es)
ES (1) ES2804500T3 (es)
IN (1) IN2014MU00193A (es)
NZ (1) NZ728036A (es)
RU (1) RU2705375C2 (es)
WO (1) WO2015110950A1 (es)
ZA (1) ZA201700064B (es)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100278921A1 (en) * 2009-04-30 2010-11-04 Fischer Cristina M Solid oral formulation of abt-263
WO2013030733A1 (en) * 2011-08-27 2013-03-07 Wockhardt Limited 1,6- diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections
RU2509560C1 (ru) * 2013-03-22 2014-03-20 Общество С Ограниченной Ответственностью "Валента-Интеллект" Новые терапевтические комбинации миртазапина для применения при болевых расстройствах

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8796257B2 (en) 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
PL2857401T3 (pl) * 2012-05-30 2020-02-28 Meiji Seika Pharma Co., Ltd. NOWY INHIBITOR ß–LAKTAMAZY I SPOSÓB JEGO WYTWARZANIA
CN104884092A (zh) * 2013-01-14 2015-09-02 沃克哈特有限公司 用于治疗细菌感染的组合物和方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100278921A1 (en) * 2009-04-30 2010-11-04 Fischer Cristina M Solid oral formulation of abt-263
WO2013030733A1 (en) * 2011-08-27 2013-03-07 Wockhardt Limited 1,6- diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections
RU2509560C1 (ru) * 2013-03-22 2014-03-20 Общество С Ограниченной Ответственностью "Валента-Интеллект" Новые терапевтические комбинации миртазапина для применения при болевых расстройствах

Also Published As

Publication number Publication date
AU2015208830A1 (en) 2017-04-27
RU2017110457A (ru) 2018-10-03
CA2954553C (en) 2022-12-06
IN2014MU00193A (es) 2015-08-28
EP3217979B8 (en) 2020-06-03
ES2804500T3 (es) 2021-02-08
US10322116B2 (en) 2019-06-18
US20180104224A1 (en) 2018-04-19
EP3217979A1 (en) 2017-09-20
CA2954553A1 (en) 2015-07-30
US20170202813A1 (en) 2017-07-20
NZ728036A (en) 2019-12-20
BR112017003444A2 (pt) 2023-03-07
WO2015110950A1 (en) 2015-07-30
EP3217979B1 (en) 2020-04-08
AU2020201956B2 (en) 2020-07-09
ZA201700064B (en) 2018-08-29
AU2020201956A1 (en) 2020-04-02
RU2017110457A3 (es) 2018-10-03

Similar Documents

Publication Publication Date Title
WO2015159265A1 (en) Pharmaceutical compositions comprising antibacterial agents
JP6886996B2 (ja) 抗菌剤を含む医薬組成物
US20160296502A1 (en) Antibacterial compositions
US9789097B2 (en) Pharmaceutical compositions comprising antibacterial agents
US20170065566A1 (en) Pharmaceutical combinations comprising antibacterial agents
RU2705375C2 (ru) Фармацевтические композиции, содержащие антибактериальные агенты
US20170000775A1 (en) Pharmaceutical compositions comprising antibacterial agents
AU2014338612A1 (en) Pharmaceutical compositions comprising antibacterial agents
US20160287571A1 (en) Pharmaceutical compositions comprising antibacterial agents
EP3131555A1 (en) Pharmaceutical compositions comprising antibacterial agents
US20170151221A1 (en) Pharmaceutical compositions comprising cefepime or sulbactam
WO2018193368A1 (en) Antibacterial compositions
BR112017003444B1 (pt) Composições farmacêuticas compreendendo ertapenem e um composto de fórmula (i)